Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravenous Immunoglobulin”

457 trials

Showing 20 of 457 results

Early research (Phase 1)Study completedNCT00352131
What this trial is testing

Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors

Who this might be right for
Non-colorectal CancerPancreatic Cancer
ImmunoGen, Inc. 50
Early research (Phase 1)Study completedNCT01803867
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 72
Large-scale testing (Phase 3)Study completedNCT02269163
What this trial is testing

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

Who this might be right for
Primary Immunodeficiency
Prometic Biotherapeutics, Inc. 82
Testing effectiveness (Phase 2)Ended earlyNCT01440179
What this trial is testing

SAR3419 in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphocytic Leukaemia
Sanofi 100
Not applicableStudy completedNCT01666795
What this trial is testing

Autoantibody Specificity and Response to IVIG in ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Shandong University 672
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Testing effectiveness (Phase 2)Ended earlyNCT02915263
What this trial is testing

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Who this might be right for
Diabetes ComplicationsDiabetes MellitusDiabetic Neuropathies
Beth Israel Deaconess Medical Center 13
Not applicableEnded earlyNCT00586716
What this trial is testing

Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients

Who this might be right for
End Stage Renal Disease
Loma Linda University 22
Early research (Phase 1)Looking for participantsNCT05967299
What this trial is testing

Study of Intravenous ZMA001 in Healthy Subjects

Who this might be right for
Pulmonary Arterial Hypertension PAH
National Heart, Lung, and Blood Institute (NHLBI) 96
Early research (Phase 1)Study completedNCT03083171
What this trial is testing

Adrecizumab-LPS Study

Who this might be right for
Healthy Volunteers
Adrenomed AG 24
Testing effectiveness (Phase 2)Study completedNCT01300728
What this trial is testing

Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Sutter Health 52
Early research (Phase 1)Study completedNCT00138411
What this trial is testing

Monoclonal Antibody for Treatment of Inhalation Anthrax

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)WithdrawnNCT03492710
What this trial is testing

Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency

Who this might be right for
Primary Immune Deficiency Disorder
Green Cross Corporation
Large-scale testing (Phase 3)Looking for participantsNCT06742190
What this trial is testing

Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy

Who this might be right for
Multifocal Motor Neuropathy (MMN)MMN
argenx 115
Early research (Phase 1)Ended earlyNCT01320020
What this trial is testing

A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients

Who this might be right for
Epithelial Cancer Patients
Neovii Biotech 16
Large-scale testing (Phase 3)Study completedNCT01461018
What this trial is testing

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 22
Testing effectiveness (Phase 2)Study completedNCT01757418
What this trial is testing

Intravenous Gammaglobulin for Sickle Cell Pain Crises

Who this might be right for
Sickle Cell DiseasePain
Albert Einstein College of Medicine 300
Early research (Phase 1)Study completedNCT01952444
What this trial is testing

Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 40
Large-scale testing (Phase 3)Study completedNCT02277444
What this trial is testing

Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 130
Testing effectiveness (Phase 2)WithdrawnNCT02980263
What this trial is testing

Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease

Who this might be right for
Kawasaki Disease
Novartis Pharmaceuticals
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation